| |
|
SOSTDC1-156 |
CTNND1-211 |
CLDND1-69 |
CCNG2-231 |
TFAM-231 |
TOP3B-628 |
MYBBP1A-1134 |
MYBBP1A-1306 |
| HD |
Average |
1730 |
2302 |
4518 |
2053 |
3374 |
1799 |
1739 |
2505 |
| SD |
442 |
884 |
2,329 |
492 |
2,882 |
367 |
433 |
676 |
| Cut-off value |
2,613 |
4,071 |
9,176 |
3,036 |
9,139 |
2,532 |
2,606 |
3,858 |
| Total No. |
111 |
111 |
111 |
111 |
111 |
111 |
111 |
111 |
| Positive No. |
5 |
6 |
5 |
5 |
1 |
5 |
6 |
3 |
| Positive (%) |
4.50% |
5.40% |
4.50% |
4.50% |
0.90% |
4.50% |
5.40% |
2.70% |
| SLE |
Average |
2,211 |
3,049 |
3,780 |
2,994 |
4,283 |
2,319 |
2,149 |
3,215 |
| SD |
968 |
2,992 |
2,606 |
5,308 |
4,169 |
2,321 |
1,974 |
3,101 |
| Total No. |
84 |
84 |
84 |
84 |
84 |
84 |
84 |
84 |
| Positive No. |
13 |
8 |
4 |
10 |
1 |
11 |
10 |
11 |
| Positive (%) |
15.50% |
9.50% |
4.80% |
11.90% |
1.20% |
13.10% |
11.90% |
13.10% |
| P (vs HD) |
0.000048 |
0.029 |
- |
0.109 |
0.089 |
0.045 |
0.065 |
0.042 |
|
| Table 3: Comparison of serum antibody levels between HD and SLE patients examined by AlphaLISA. Shown are average, SD, cut-off values (average + 2SD), total sample numbers, the number of positive sera of which the antibody levels were higher than the cut-off value, and the positive rate (%) of HD; average, SD, total sample number, number of positive sera of which the antibody levels were higher than the cut-off value, and the positive rate (%) of SLE patients; and P value of comparison between HD and SLE patients. P values lower than 0.05 and positive rates higher than 10% were marked in bold. |
